Skip to content
Toggle Navigation
Home
About
Mission
History
Leadership Team
Board of Directors
Scientific Advisory Board
Message from the CEO
Products
About Barium
SmoothX
Product Information
Clinical Data
Pipeline
Sustainability
News
Investors
Contact
Voyageur Pharmaceuticals Announces IRR of 137% & NPV of $344 Million from Preliminary Economic Assessment for the Frances Creek Pharmaceutical Barium Project
Published On: January 11, 2022
|
Categories:
Company News
|
PEA News Jan 11 2021 (1)
Previous
Next
Page load link
Go to Top
